The T cell as a bridge between innate and adaptive immune systems: Implications for the kidney  by Rabb, Hamid
Kidney International, Vol. 61 (2002), pp. 1935–1946
PERSPECTIVES IN BASIC SCIENCE
The T cell as a bridge between innate and adaptive immune
systems: Implications for the kidney
HAMID RABB
Nephrology Division, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
The T cell as a bridge between innate and adaptive immune explain in vivo observations in kidney disease. Thus,
systems: Implications for the kidney. immunologic studies of kidney diseases can lead to new
The immune system is classically divided into innate and treatments, as well as expand current immunologicadaptive components with distinct roles and functions. T cells
models.are major components of the adaptive immune system. T cells
Classically, the immune system has been divided intoare firmly established to mediate various immune-mediated
kidney diseases and are current targets for therapy. Ischemic innate and adaptive components with distinct roles and
acute renal failure, a major cause of native kidney and allograft functions [11]. The innate immune system comprises the
dysfunction, is mediated in part by inflammatory components
nonspecific resistance to pathogens, whereas adaptive im-of the innate immune system. However, recent data from ex-
munity is characterized by antigen specificity and immuno-perimental models in kidney as well as liver, intestine, brain
and heart implicate T cells as important mediators of ischemia logic memory. In this review, key components of the innate
reperfusion injury. These data reveal new insights into the and adaptive immune responses will be discussed, includ-
pathogenesis of ischemic acute renal failure, as well as identify ing recent data supporting significant crossover functions
novel and feasible therapeutic approaches. Furthermore, the
of select components of each system. New data will thenidentification of T cells as a mediator of early alloantigen-
be presented supporting a role for the T cell as a newlyindependent tissue injury demonstrates that the functional ca-
pacity of T cells spreads beyond adaptive immunity into the recognized mediator of the innate immune response both
realm of the innate immune response. in kidney and extrarenal organs. I apologize in advance
for the inadvertent omission of key references.
There is increasing evidence for the immunopathogen-
INNATE IMMUNE SYSTEMesis of renal diseases that were previously not recognized
to have an immune basis [1]. Ischemia-reperfusion injury Although it has been long appreciated that host de-
(IRI) to the kidney, a major cause of acute native kidney fense depends on both innate and adaptive immune re-
and allograft dysfunction, is now established to involve sponses, the main focus of immunology research over
components of the immune system [2–7]. In addition, the 30 years has been on the adaptive response [12].
there is increasing awareness of the interrelationship be- More recently, there has been renewed interest in the
tween immunologic and non-immunologic factors in kid- innate immune response. Much of the basic work on the
ney diseases previously felt to be solely of immune or innate system has been performed in insects. Drosophila
non-immune etiology [8–10]. Chronic progressive renal has been a particularly fertile model, with a well-charac-
dysfunction in native kidneys, as well as allografts, typi- terized resistance to microbes employing effector mole-
fies conditions where these interrelationships are becom- cules with overlapping functions during morphogenesis.
ing evident. A broad overview of the immune response Many Drosophila genes are up-regulated by septic in-
is therefore important for those studying or caring for jury, activating transcription factors of the nuclear factor-
the patient with renal disease. At the same time, immune kappa B (NF-B) and Rel families [12]. Close evaluation
paradigms developed from in vitro studies may not fully of these proteins elucidated striking similarities with cy-
tokine-induced NF-B dependent acute phase response
genes in mammals. Another insect, the moth, was theKey words: T cell, acute renal failure, ischemia reperfusion, innate
immunity, adaptive immunity. original source of discovery of inducible antimicrobial
peptides [13]. Over 400 antimicrobial peptides of theReceived for publication July 11, 2001
innate immune system subsequently have been identifiedand in revised form February 4, 2002
Accepted for publication February 5, 2002 in different species. Study of the response of the African
mosquito Anopheles, which harbors the deadly Plasmo- 2002 by the International Society of Nephrology
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dium malaria parasite, has also yielded considerable in- [11]. These pathogen-associated structures are produced
by pathogens, are usually essential to the microorganism,formation on mechanisms through which the innate im-
mune system mounts successive multisite responses both and are usually present throughout entire classes of
pathogens. Receptors for pathogen-associated moleculeslocally and systemically [14]. These comparative studies
with the human innate response have had a major impact are found on macrophages, dendritic cells, and B cells.
Once bound, these receptors directly activate effectorin our current understanding of this field.
The innate “hard-wired” immune system mounts an functions. Well-characterized receptors of the innate im-
mune system include mannan-binding lectin (which pro-immediate response that is stereotypic, generic in nature,
and is felt to lack immunologic memory. Innate immunity motes complement activation) [22], and the macrophage
mannose receptor (facilitates endocytosis of pathogenshas evolutionary links to invertebrate phyla. The mam-
malian innate system is composed of plasma proteins and presents the derived proteins by MHC molecules
on the surface) [23].(such as complement), cells [neutrophils, macrophages
and natural killer (NK) cells] and physical barriers (Fig. 1) Recently, a new family of receptors, called “toll” re-
ceptors, has been invoked in the initiation of innate im-[15]. The neutrophil is the major phagocyte that responds
rapidly to infection or trauma. Neutrophil mobility to munity. These transmembrane proteins were originally
identified in Drosophila as regulators of dorsoventralsites of inflammation and the ensuing phagocytosis are
enhanced by specific IgG antibodies and complement polarity [24]. At least 10 mammalian toll receptors have
been identified, and the toll-like receptor-4 (TLR-4) is(C3) [16]. These opsonins facilitate phagocytosis. Low
molecular weight cytokines (chemokines) attract and ac- important in lipopolysaccharide recognition and respon-
siveness [25, 26]. TLR-4 also plays an important role intivate neutrophils, as well as initiate and mediate in-
flammatory responses for both innate and adaptive im- innate immunity to respiratory syncytial virus [27] and
Treponema family bacteria [28]. Furthermore, this re-mune systems [17]. Complement amplifies the innate
immune response through three different pathways: two ceptor mediates macrophage migration inhibitory factor
independent of antibody (Ab)-antigen (Ag) complexes, (MIF) signaling in macrophages [29]. TLR-4 and other
and the third requiring Ab-Ag complexes for activation. toll-like receptors are fertile area of investigation for
The final effector mechanism for all three is the forma- new insights into innate immunity.
tion of the active membrane attack complex. The alterna-
tive pathway is activated via interaction with specific
ADAPTIVE IMMUNE SYSTEMmembrane components of pathogens, while the classic
The adaptive immune response is felt to have devel-pathway requires specific Ab bound to antigen for activa-
oped approximately 450 million years ago when a transpo-tion. Complement also serves as an immunoregulator of
son that carried the primitive variants of the recombinasethe immune response. Complement activation is tightly
activating genes, RAG-1 and RAG-2, became insertedcontrolled by inactivation of free complement in plasma.
into the germ line of jawed vertebrates [30]. The adaptiveIn addition, complement is regulated by several inhibi-
immune system responds to antigenic challenge withtory proteins, such as C1 inhibitor and decay-accelerating
specificity that requires antigen receptors that can recog-factor. Defects in these inhibitors lead to diseases such
nize millions of different molecular structures. At rest,as hereditary angioedema and paroxysmal nocturnal he-
the population of lymphocytes expressing a particularmoglobinuria. Complement also has been linked to the
antigen receptor specific to a particular antigen is rela-pathogenesis of ischemic injury in kidney [18] as well as
tively small. These lymphocytes constitute memory cellsother organs [19, 20]. Other leukocytes comprising the
for that specific antigen. Upon re-exposure to a particularinnate system that have cytotoxic abilities include mono-
antigen there is enormous expansion of the specific lym-cytes and NK cells. These cells can manifest cytotoxicity
phocytes. Conversely, after resolution of the antigenicwithout prior sensitization to the target. Natural killer
challenge, reductions in lymphocyte population occurcell-mediated killing appears to involve specific HLA
with residual memory cells that store information. Suchrecognition [21]. Killing occurs when the NK cell encoun-
learning augments the rapidity and vigor with which theters cells devoid of specific HLA molecules normally
organism responds to subsequent antigenic challenge.responsible for cytotoxicity-inhibiting signal. NK cells
The adaptive response is localized with precise homingalso produce cytokines that directly affect B and T cell
mechanisms of lymphocytes [31].function.
T and B cells are the major components of the adaptiveThe innate immune system recognizes and responds
immune system, and both express highly specific antigento a restricted set of highly conserved structures common
receptors on their surface (Fig. 2). B cells produce spe-to different pathogens [11]. These common structures,
cific antibodies which neutralize pathogens, facilitatecalled pathogen-associated molecular patterns, include
phagocytosis by opsonization, and activate complement.lipopolysaccharide, peptidoglycan, bacterial DNA, double-
stranded RNA, lipoteichoic acid, mannans and glucans The T cell response is mediated by the T cell receptor
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Fig. 1. Innate immunity. The innate system
provides the initial defense against infection and
injury. The primary components of innate im-
munity are: (1) physical and chemical barriers;
(2) phagocytic cells (neutrophils and macro-
phages), natural killer (NK) cells and possibly
dendritic cells; (3) blood proteins, including
members of the complement system and other
mediators of inflammation; and (4) cytokines
that regulate and co-ordinate many of the ac-
tivities of the cells of innate immunity. (Repro-
duction of this figure in color was made possi-
ble by Texas Biotech Corp., Houston, Texas.)
Fig. 2. Adaptive immunity. There are two
types of adaptive immunity: humoral and cell-
mediated. Humoral immunity is mediated by
antibodies that are produced by B lympho-
cytes. It is the principal defense mechanism
against extracellular microbes and their tox-
ins, with secreted antibodies binding to mi-
crobes and toxins to assist in their elimination.
Cell mediated immunity is mediated by T cells,
with dendritic cells playing important roles in
antigen presentation. T cells can function by
various methods: (1) activating macrophages
to kill phagocytosed microbes; (2) directly de-
stroy infected cells; and (3) by releasing cyto-
kines and alter the milieu around them. (Re-
production of this figure in color was made
possible by Texas Biotech Corp., Houston,
Texas.)
(TCR). The TCR responds to antigen peptides presented among individual genes for the receptor domains re-
ferred to as variable (V), diversity (D) and joining (J)on macrophages following phagocytosis of pathogens
(such as bacteria), and to peptides from cytosolic patho- regions of the TCR and immunoglobulin, a process de-
noted somatic recombination [32]. The association ofgens (such as viruses) presented on infected cells. Most
T cells produce a multimeric TCR with  and  chain, multiple different V, D and J regions leads to the forma-
tion of up to 1012 or more specific receptors. This randomwhile a few express the gamma () and delta () chains.
The enormous repertoire of antigen receptors is gener- process occurs early in the process of B and T cell devel-
opment prior to contact with antigen. When a specificated during immunologic development by rearrangements
Rabb: The T cell and innate and adaptive systems1938
Fig. 3. Antigen dependent and antigen inde-
pendent T cell activation. Several integral mem-
brane proteins are involved in antigen recog-
nition and functional responses expressed on
T cells. They specifically bind ligands present
on antigen presenting cells (APCs) and in-
crease the strength of adhesion between a
T cell and an APC. Many accessory molecules
may transduce biochemical signals to the inte-
rior of the T cell and they are able to regulate
immune responses. Recent evidence suggests
that T cells also can be activated by antigen
independent pathways. Oxygen free radicals,
cytokines and RANTES have all been impli-
cated in directly causing T cell activation. (Re-
production of this figure in color was made
possible by Texas Biotech Corp., Houston,
Texas.)
Fig. 4. Potential mechanisms of T cell involve-
ment in ischemia-reperfusion injury (IRI). Lo-
cal effect: In the blood vessel T cells can bind
to macrophages, platelets, neutrophils and en-
dothelium. This amplifies the microcirculatory
sludging and “no-flow” state. Within the inter-
stitium, T cells can contact APCs or be acti-
vated by injury signals with an APC. Adjacent
to epithelium, T cells can directly damage epi-
thelial cells, as well as regulate epithelial cell
function. Distant effect: T cells may be exerting
an effect also from a distant site such as the
thymus, bone marrow, lymph nodes and
spleen. T cells lodged in these sites could re-
lease cytokines and chemokines that are hav-
ing an effect on inflammatory mediators in the
kidney. Furthermore, these distant sites are
where T cells traffic for education, expansion
and deletion. (Reproduction of this figure in
color was made possible by Texas Biotech
Corp., Houston, Texas.)
receptor has been expressed, it becomes the only antigen and respond to the infection or injury. The innate im-
mune system has traditionally been viewed as a temporiz-recognition structure expressed by that lymphocyte and
its progeny. The process of activation and proliferation ing defense mechanisms, acting until the lymphocyte can
take over, and that the innate immune system basicallyof a lymphocyte after encountering an antigen is termed
clonal selection, which is the basic property of the adap- primes the adoptive response [11]. However, the interac-
tions between the two are much more complex. Recenttive immune response. It takes three to five days for
enough clones to be produced and differentiate into ef- evidence implicates relationships between the innate im-
mune response as determinants whether the antigen,fector cells [11]. It is in this early phase that effector
mechanisms of the innate immune system are activated foreign or native, will induce an immune response.
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CD4 cells function as both helper and regulatory a localized and rapid release of IFN-, which precedes
 T cell activation by hours and days. Thus, it has beencells, fulfilling these roles via direct cell-cell interactions
as well as by secretion of many cytokines. One model felt that  responses may influence the  response
[40]. Gamma delta T cells can also modulate cytokineof T cell activation posits that at least two different sig-
nals are necessary to activate T cells. The first signal production by NK cells [41]. Thus, the  cell may be an
important link between innate and adaptive immunity.arises from TCR binding of the complex of antigen frag-
ment and HLA. The second involves a costimulatory There are many other examples of links between innate
and adaptive immunity, including the observation thatsignal mediated by, CD80 (B7-1) and CD86 (B7-2) mole-
cules (Fig. 3) [11]. In the absence of CD80 or CD86 toll receptors of the innate immune system induce the
B7 variants, CD80 and CD86, which in turn mediatecostimulation, antigen recognition leads to inactivation
or apoptosis of the T cell. adaptive immune responses [11].
EVIDENCE SUPPORTING A ROLE FORCURRENTLY ESTABLISHED LINKS
BETWEEN THE INNATE AND ADAPTIVE T CELLS AS A MEDIATOR OF INNATE
IMMUNITY IN EXTRARENAL ORGANSIMMUNE SYSTEM
Key links between innate and adaptive immune sys- The immune response to tissue injury is (1) immediate,
and (2) does not require alloantigen stimulation. Theretems include the antigen presenting dendritic cells (DC),
found at the sites of entry into the body, for example, are many modes of tissue injury where the innate im-
mune system is activated: ischemia reperfusion injury,skin, lungs, kidney, and liver, bind and ingest invaders.
DCs are components of the innate immune system that burns, crush injuries, envenomation, etc. IRI is becoming
increasingly well characterized both clinically and scien-then transfer information to the adaptive immune system
[33]. DCs also are activated by other components of the tifically, and will be the focus of the remainder of this
discussion. The pathogenesis of IRI is complex, but in-innate system, which allow DC to carry antigen to lymph
nodes (LNs), where it is presented to T and B cells to flammation is an established feature. Extensive studies
on IRI have been performed in the heart, brain andinitiate the adaptive response. Dendritic cells release
interferon- (IFN-), which then further triggers a cas- intestine. It is believed that oxygen free radicals and
mitochondrial products are important initiators of cellu-cade of antigen-nonspecific responses mediated by the
innate immune system. Penfield et al have found that lar and soluble components of the innate immune re-
sponse during IRI [42]. Complement is activated, partic-during renal IRI, dendritic cells migrate into the kidney
[34]. This could be a central event by which the innate ularly via the alternative pathway, generating fragments
such as C3a and C5a. This process leads to a release ofand adaptive immune systems are linked in renal IRI.
Natural killer cells are a subset of lymphocytes found histamine, platelet activating factor, a host of cytokines,
with attendant increase in vascular permeability. Neu-in blood, lymphoid tissue, and especially spleen [35]. NK
cells lack the TCR for antigen recognition and possess trophils and endothelium are activated, with up-regula-
tion of the adhesion molecules including CD11/CD18,the ability to kill tumor cells or host cells infected by
virus. NK cells do not require prior contact with target ICAM-1 and P-selectin. Neutrophil/platelet aggregates
promote microvascular plugging (“white clot”) and emi-antigens to develop cytolytic properties, though NK cells
can acquire specificities using their Fc receptor that binds gration of neutrophils into tissue results in local destruc-
tion. Macrophages also infiltrate in a more delayed fash-to IgG-coated target cells. NK cells use numerous pore
cell toxins. T cell, particularly CD4 cells, can stimulate ion, and likely contribute to repair. Thus, the PMN is the
central leukocyte observed in tissue necrosis followingNK cell functions. Therefore, NK cells, though members
of the innate immune response, have a number of ways ischemia. Based on the above, the T cell, seen only in
small numbers during necrosis, would not be expectedof interacting with adaptive immune responses.
T cells bearing the gamma-delta () form of the T cell to play a major role in this process, at least on theoretical
grounds. Traditional paradigms concluded that, “thereceptor are a minor population of T cells in lymphoid
organs and the circulation, but a prominent population lymphocytes plays very little, if any, role in the acute
phases of inflammation, but principally contributes toin skin, intestine and lung [36]. Gamma-delta T cells can
recognize structures presented by microorganisms and reactions in chronic long-standing inflammatory pro-
cesses” [43]. Recent data, however, challenge this model.stressed cells, as do macrophages [37]. Presentation of
antigen to  T cells bypasses the usual processing path- The persistent clinical dilemmas of managing patients
with IRI and new experimental tools have fueled in-ways required for peptide association to MHC molecules
[38]. There is also a primary sequence difference between creased research in the early inflammatory response dur-
ing IRI. There is now both indirect and direct evidenceamino acids that make up  TcRs and the conventional
 T cells [39]. Gamma delta cells are characterized by that T cells are important mediators of IRI, even in the
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Table 1. Evidence for pathogenic role of T cells in gut, heart and lung ischemia/reperfusion injury
Organ Model Species Intervention/Effect Reference
Liver Cold ischemia Rat Tacrolimus protective Kawano 1996 [44]
Decreased leukocyte adhesion
Liver IRI Rat Tacrolimus protective Garcia 1998 [45]
Intestine Decreased leukocyte adhesion
Liver Partial lobe Mouse T cell deficient (nu/nu) mice protected Zwacka 1997 [46]
subacute phase CD4 depletion protective in wild types
T cells modulated neutrophil infiltration
Liver IRI Mice T cell deficient (SCID) mice protected Horie 1999 [47]
CD4 population more important than CD8 cells in this effect
Liver IRI Rat FTY 720 with cyclosporine protective, but FTY 720 alone was not Mizuta 1999 [48]
protective
Liver Ex vivo cold Mouse nu/nu mice protected Le Moine 2000 [49]
ischemia IL-10 protective
Resident T cells important
Intestine IRI Rat Cyclosporine and rapamycin protective Puglisi 1996 [50]
Heart Transplant Rat Mycophenolate protective Valentin 2000 [51]
Decreased leukocyte adhesion
Heart Infarction Rat Cytotoxic T cells activated that kill non-ischemic myocytes Varda 2000 [52]
Lung Cold IRI Canine Increased natural killer activity in lavage Adoumie 1992 [53]
increased MHC II expression in 24 hours
Lung Cold IRI Swine Platelet-activating factor blockade protective, possibly by Nikbakht 2000 [54]
decreasing T cell activation
Lung Transplant Rat Antithrombin III treatment protective, possibly by decreasing Okada 1999 [55]
T cell proliferation
Brain Focal ischemia Rat Tacrolimus but not rapamycin nor cylcosporine protective; im- Sharkey 1994 [56]
munophilin pathway invoked
absence of alloantigen, and that they act in the early to reduce hepatic IRI injury in rats [44]. These effects
appeared to be independent of Kupffer cell phagocyticinjury period. These observations shift the classical role
of the T cell, suggesting that it may play an important activity. In a separate study using FK506 in both liver
IRI as well as mesenteric IRI in rats, tissue protectionrole in the early inflammatory response rather than func-
tioning exclusively as a component of the adaptive im- correlated with decreased intercellular adhesion mole-
cule-1 (ICAM-1) and P-selectin expression as well asmune response.
There are abundant experimental studies in many non- decreased leukocyte rolling [45]. The authors attributed
the protection afforded by FK506 to its effect on adhe-renal organs identifying the presence of T cells after IRI.
These will not be enumerated. However, it should be sion molecule expression. However, other interpreta-
tions also may be valid, as FK506 is known to exertnoted that though numerous studies have demonstrated
a delayed influx occurring after the clear functional dete- its effects by altering ischemia-induced ceramide and
apoptosis signaling [57]. A study using cyclosporine Arioration of tissue, T cells have generally not been sought
or rigorously identified with definitive techniques. Very and rapamycin, which both impair T cell activation as
their main functions, demonstrated attenuated smallearly times (first few minutes, hours) have rarely been
examined. Furthermore, descriptions do not usually dis- bowel IRI in rats [50]. The first direct proof of the role
for T cells in IRI came from a series of elegant studiestinguish intravascular accumulation of T cells in the early
no-reflow state of IRI, compared to the overt extravasa- on mouse liver. In the subacute phase of liver injury (16
to 20 hours postischemia), a marked preservation of livertion out of the microcirculation. This is an important
distinction, and one that has not been thoroughly ad- function was found in T cell-deficient athymic mice com-
pared to wild type BALB/c strain [46]. This was associ-dressed to date. Presence or absence of the T cell is
further confounded by the potential for T cells to be ated with a marked decrease in neutrophil infiltration.
Adaptive transfer of wild type T cells into the athymicsequestered in sites of inflammation as “innocent by-
standers.” Therefore, the following focus will be on stud- (nu/nu) mice restored the neutrophil-mediated injury.
In vivo depletion of CD4 cells, but not CD8 cells inies that have used techniques to assess cause and effect,
as well as transferability. wild type mice was also protective. Similarly, mice with
severe combined immunodeficiency (SCID) also wereSome of the most convincing evidence for T cell
involvement in renal IRI comes from studies of the gut protected from liver IRI, and that T cell adoptive transfer,
particularly of CD4 cells, restored injury [58]. These(Table 1) [44–56]. The calcineurin inhibitor FK506 (ta-
crolimus) used to prevent T cell-mediated allograft rejec- results were confirmed and extended by experiments that
found that T cell-deficient mice to be relatively resistanttion as well as other autoimmune diseases, was found
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to liver IRI. In this ex vivo model of IRI, it was the resident effect of FK506. Both rapamycin and FK506 compete
for the same common binding site on lymphocyte FKand not infiltrating T cells that played the important role,
and interleukin-10 (IL-10) modulated this T cell re- binding protein.
sponse [49]. A potential mechanism by which T cells
mediated IRI was revealed by examining the effects of
EVIDENCE SUPPORTING A ROLE FOR
CD4 cell reconstitution into severe combined immuno-
T CELLS AS A MEDIATOR OF INNATE
deficient mice (SCID) with bowel inflammation. In this
IMMUNITY IN THE KIDNEY
work, CD4 cells, particularly those whose surface ex-
Unlike heart or gut, where neutrophils are well estab-pression of CD45RB was high, were found to up-regulate
lished to be important mediators of IRI, the role ofa variety of T helper-1 (Th1) and macrophage-derived
neutrophils in renal IRI is controversial and not as wellcytokines, as well as leukocyte adhesion molecules [59].
established [62]. Treatment of rats [63] and mice [64]Attempts to further elucidate the mechanisms of T cell-
with neutrophil depleting antiserum reduced postische-mediated up-regulation of cell adhesion have been con-
mic acute renal failure. However, use of neutrophil de-ducted in vitro on hypoxic human umbilical vein cells
pleting serum in rats undergoing renal IRI was not found(HUVEC). T cell adhesion to HUVECs stimulated sub-
to be protective by other groups [65, 66]. Elegant ex vivosequent neutrophil adhesion to HUVEC, as well
techniques have demonstrated that infused neutrophilsas up-regulation of vascular cell adhesion molecule I
can synergize with ischemia to cause acute renal failure(VCAM-1). Tumor necrosis factor- (TNF-) was felt
[67]. Certain compounds that protect renal function andto be the key factor that linked T cell adhesion to VCAM-1
tubular structure during experimental acute renal failureexpression [60].
attenuate neutrophil influx into injured kidney, prompt-An early study of the effects of IRI on lung trans-
ing the interpretation that the compounds worked byplantation using canines found that within one to four
inhibiting neutrophil infiltration. This has been demon-hours of reperfusion, there was a marked influx of lym-
strated in the case of adenosine receptor blockade, whichphocytes (and neutrophils) accompanied by an increase
protects renal function after IR and attenuates myelo-in lectin-mediated cytotoxicity and natural killer cell cyto-
peroxidase activity, a marker of tissue neutrophils [68].toxicity [53]. The authors also found an increase in MHC
Interleukin-18 blockade in mice also results in tissue pro-class II expression, concluding that IRI could render
tection and decreased myeloperoxidase levels [69]. Alpha-lungs more susceptible to rejection. Another interven-
melanocyte stimulating hormone (-MSH) markedly re-tional study with indirect evidence that T cells were medi-
duced renal neutrophils and attenuated renal IRI [7].ating lung IRI was performed in swine. Pig lung undergo-
However, subsequent study of -MSH demonstrated thating IRI was protected from edema by platelet activating
the mechanism of action was independent of neutrophilsfactor antagonism, which also decreased T cell activation
[70]. Others have recently demonstrated that many ofand infiltration [54]. In a separate study using rat lungs
the studies that identified neutrophils in acute renal fail-undergoing IRI, antithrombin III, with potent antithrom-
ure mistakenly evaluated macrophages instead: myelo-botic and inflammatory properties was found to be pro-
peroxidase, chloroacetate esterase, and “neutrophil-tective; however, this agent also decreased T cell prolifer-
specific mAb HIS-48” all cross-reacted with macro-ation, a mechanism of protection being speculated in the
phages [71]. Furthermore, both in sheep [72] and in ratsinterpretation of the results [55]. In the heart, though
[73] neutrophil infiltration into postischemic kidney hasmuch evidence exists for leukocyte mediation of reperfu-
been dissociated from direct role in tissue injury. It ission events and the presence of lymphocytes postischemia,
quite possible that the neutrophil has been overesti-there is little supportive evidence yet for a direct role of
mated as a pathophysiologic factor in renal IRI due toT cells. Abnormalities are found in circulating T cells
the prominent influx observed in experimental models.associated in humans with myocardial ischemia or in-
A series of experimental studies demonstrated an im-farction [61]. An elegant mechanistic study of myocardial
portant role for the leukocyte adhesion molecules CD11/infarction using rats found that T cells became activated
CD18 and ICAM-1 in renal IRI [3, 4, 64, 74, 75]. Theseby the cardiac injury, and also retained a memory re-
studies also were interpreted as demonstrating an impor-sponse against myocytes [52]. Though there are abun-
tant role for neutrophils during IRI, but this was notdant data on T cell infiltration after brain IRI, only lim-
conclusive due to the observations of many groups thatited data to date found a direct role for the T cell.
induction of neutropenia did not lead to protection fromAdministration of FK506 in a rat model of focal cerebral
IRI [58]. In fact, it was observed that of severe neutro-artery occlusion significantly reduced infarct size [56].
penia was not protective in the identical model thatInterestingly, the related immunophilin, cyclosporine as
CD11/CD18 and ICAM-1 blockade worked (abstract;well as the T cell activation inhibitor rapamycin did not
Mendiola et al, J Am Soc Nephrol 4:741, 1993). A possi-protect at the doses administered. In fact, rapamycin
given together with FK506 blocked the neuroprotective ble interpretation is that CD11/CD18 or ICAM-1 block-
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Table 2. Indirect evidence for a role for T cells in renal IRI
Model Species Findings References
Biopsies Human Mononuclear cells, not neutrophils, in vasa recta during acute renal failure Solez 1979 [76]
IRI Rats Tacrolimus pretreatment protective, potentially by regulating TNF release Sakr 1992 [77]
IRI Rats CD11/CD18 (expressed on T cells as well as other leukocytes) blockade protective. Rabb 1994 [3]
Neutrophil depletion not protective in parallel studies
IRI Rats CD11/CD18 & ICAM-1 blockade protective, need to give intervention early for effect Kelly 1994 [4]
IRI Rats ICAM-1 blockade protective during severe ischemia Rabb 1995 [74]
IRI Mice ICAM-1 knockout protective Kelly 1996 [64]
Reduced myeloperoxidase content of injured kidney
IRI Rats ICAM-1 antisense oligonucleotides protective Haller 1996 [75]
Transplant Human Anti-CD11a/CD18 therapy decreased delayed graft function Hourmant 1996 [78]
IRI Rats Mycophenolate protective when combined with bioflavinoids Jones 2000 [79]
ade, which has profound effects on T cell function, could post-ischemia (within 24 hours) despite the use of differ-
have also worked via action on T cells (Table 2) [3, 4, ent antibodies to detect T cells. When CD4 cells defi-
64, 74–79]. As in liver IRI, FK506 was found to also cient in CD28 or IFN- were adoptively transferred,
attenuate experimental renal IRI in rats [77]. In addition, injury was not restored, thus revealing the important
mycophenolate mofetil, which has for the most part re- role for CD28 and IFN- in renal IRI [84]. To evaluate
placed azathioprine in most clinical T cell suppression if alloantigen-independent factors could activate T cells
regimens, also confers protection from renal IRI [79]. in a nephrotrophic manner, T cells were incubated with
Furthermore, a significant reduction in early injury after renal epithelial cells in hypoxia-reoxygenation condi-
cold renal IRI was afforded by blockade of the T cell tions, resulting in increased T cell adhesion to renal epi-
CD28-B7 costimulatory pathway with CTLA4Ig (a re- thelial cells compared to that in normoxic conditions
combinant fusion protein that contains a homolog of [83]. More recently, use of the B7-1 Ab to CD80 but
CD28 fused to an IgG1 heavy chain) [80]. This work was not B7-2 Ab to CD86 also abrogated renal IRI in rats,
extended to a long-term model of progressive protein- demonstrating that is was likely the B7-1 pathway that
uria in uninephrectomized rats that underwent cold IRI was blocked in the CTLA4Ig work [86]. These data fur-
[81]. CTLA4Ig treatment on the day of injury, as well ther strengthened the argument for role for T cells in
as delayed treatment one week beyond ischemia (but not renal IRI. Thus, there is now ample evidence from differ-
four weeks), was effective in reducing proteinuria [81]. ent labs using diverse techniques of an important role
One interpretation was that CTLA4Ig could have had for T cells in the immediate response to renal ischemic
other effects besides involving specific T cell activation injury (Table 3) [79–84, 86]. As yet there are insufficient
[82]. To test the hypothesis if T cells were directly in- data to extend these conclusions to humans. However,
volved in renal IRI, mice deficient in CD4 and CD8 cells it is important to note that in human kidney biopsies of
were evaluated and found to be protected from renal acute renal failure, mononuclear leukocytes, not neutro-
IRI [83]. Knockout mice, however, can have additional phils, have been observed in the vasa recta [76]. In addi-
changes besides the targeted disruption. Therefore, an- tion, studies using thymoglobulin induction to prevent
other T cell knockout mouse strain was used, the athymic allograft rejection “serendipitously” reduced delayed
nu/nu mice. This mouse was also protected from renal graft function, the major manifestation of renal IRI in
IRI [84]. Furthermore, adoptive transfer of T cells into the cadaveric transplant (abstract; Goltz et al, Trans-
these mice restored ischemic injury-potentially fulfilling plantation 67:S388, 1999).
the “transferability” that Koch required among his clas-
sic postulates [85]. To identify the relative contribution
POTENTIAL MECHANISMS BY WHICH THEof CD4 and CD8 T cell subsets in renal IRI, individual
T CELL COULD BE A MEDIATOR OF THECD4 and CD8 knockout mice were studied, with the
INNATE IMMUNE RESPONSE SYSTEMCD4 knockout showing a marked protection from both
The most widely accepted model of the immune re-renal injury and mortality after IRI [84]. Adoptive trans-
sponse is the “self–non-self” model, where the immunefer of the wild-type CD4 cells into these knockout
response recognizes exogenous signals that represent amice also led to a worsening injury phenotype, directly
form of non-self. However, an emerging model is thedemonstrating the importance of CD4 cells in renal
“danger” model, which proposes that the signals initiat-IRI. Surprisingly, the neutrophil and macrophage in-
ing the immune response are inherent in the normalfiltration into postischemic kidney was not affected by
body tissues themselves [87]. The self–non-self model aseither the nu/nu or CD4 knockout, nor the adoptive
transfer. Very few infiltrating T cells were seen early well as danger model propose that antigen presenting
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Table 3. Direct evidence for a pathogenic role for T cells in renal IRI
Model Species Findings Reference
Cold ischemia Rat CTLA-4 Ig protective, reduced induction of inflammatory genes Takada 1997 [80]
IRI Mouse CD4/CD8 KO mice protected, hypoxia-reanoxia alone sufficient to activate T cells to increase Rabb 2000 [83]
adhesion to kidney
IRI Mouse Athymic nu/nu & CD4 / mice protected, T cell transfer restores injury; neutrophil and Burne 2001 [84]
macrophage infiltration dissociated from protection
IRI Rat Anti-B7-1-Ab protective DeGreef 2001 [86]
cells (APCs) must be activated. However, while the self– shown to directly activate T cells [89]. RANTES up-
regulation has been shown to occur in renal IRI, so thisnon-self model is based on the view that a non-self signal
is essential, the danger model proposes that activation is one possible mechanism for T cell activation in the
absence of antigen [90]. Another stimuli now demon-of an APC depends on the health of the cells in its
neighborhood. Thus, a foreign entity that does no injury strated to be capable of activation T cells and leading
to up-regulation of pro-inflammatory genes are oxygenwill not evoke a response, while a self-entity presented by
APCs will evoke response when accompanied by injury. free radicals [91, 92]. Oxygen free radicals are one of
the most widely recognized products of tissue injury,Pre-packaged alarms could be mitochondrial products
normally inside the cell, mannose (also found normally particularly IRI, and could be playing an important role
in the T cell activation. T cells, when incubated with renalinside the cell), RNA, DNA, and inducible signals such
as heat shock proteins and toll receptors [87]. The danger epithelial cells from the same strain of inbred mouse,
C57BL6, become activated when hypoxia-reoxygenationmodel also proposes that each tissue has a set of effector
classes it prefers, so that local responses can be tapered. occurs, and increases their adhesion to these renal cells
[83]. Similarly, T cells exposed to hypoxic endothelialThus, a T cell being activated and involved in IRI could
be interpreted by the danger model as a response to cells in culture also become activated and increase their
adhesive phenotype, in part due to the production ofAPCs becoming activated by injury, and then traveling
to draining lymph nodes and up-regulating costimulatory TNF by the hypoxic cells [93].
Thus, a strong theoretical and experimental frame-molecules needed to activate T cells. After the initial
reaction by the T cells and other inflammatory pathways, work exists to explain the findings of the T cell being an
important mediator of IRI. However, what is not clearcomplete remodeling would render the tissue tolerant.
However, if remodeling was not adequate, a continued is how the T cell participates in the injury process. T cell
products are important for the optimal expression ofT cell-mediated memory response to the injury would
occur, resulting in smoldering inflammation with cycles endothelial adhesion molecules, which in turn recruit
and activate phagocytes [47]. Therefore, it is possibleof repair, which in the long run would lead to fibrosis.
This is very consistent with what we observe in the native that T cells mediate IRI via amplifying inflammation, in
particular facilitating phagocyte recruitment. However,kidney subject to injury that, once injured, seems to
progress inexorably to end stage fibrosis and failure. the role of the neutrophil in renal IRI is still not fully
defined [58]. Furthermore, neutrophil infiltration intoSimilarly, a marginal single kidney allograft with a long
cold ischemia time, after the initial acute renal failure, postischemic kidney can be dissociated from the effects
of T cell manipulation [84]. Administration of the selectin-would be expected to gradually deteriorate over time,
particularly if other insults were superimposed, such as ligand inhibitor, TBC 1269, which acts on both T cells
and neutrophils, markedly protected rat kidney structurefrom hypertension or proinflammatory effects of filtered
proteins. and function after ischemia without halting neutrophil
trafficking to postischemic kidney [94]. The observationsOne major question that arises when trying to under-
stand the mechanisms underlying the role of the T cell that brisk leukocyte trafficking into tissue can occur de-
spite tissue protection from injury has been found inin mediating IRI is the nature of the process by which
the T cell gets activated. Normally, one would expect the other disease models, including asthma [95].
The T cell has been well established to have an effectrequirement of an alloantigen in the context of co-stimula-
tory signals [88]. In IRI without the presence of an alloan- on renal tubular epithelial cells, and the damage to these
cells is the hallmark of IRI, or acute tubular necrosis.tigen, such as in native kidney IRI, one could invoke the
unveiling of a self-antigen presented by an APC that However, very few T cells are seen around the epithelium
in IRI, unlike in acute transplant rejection, making itwas normally not exposed to the immune system, but
somehow expressed during tissue injury. Recently, T cell less likely that a direct tubular epithelial toxicity can
explain the profound effects. Given the amplificationactivation has been demonstrated to occur totally inde-
pendently of antigen. The chemokine RANTES has been effects of just a few T cells and the microvascular in-
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flammation that characterizes IRI, it would not be sur- Chronic allograft nephropathy (CAN), the leading
prising if the effects of T cells were in the blood vessels challenge in long term graft function, may be influenced
themselves, with active engagement of platelets, phago- by early changes that result from IRI [100]. Thus, inter-
cytes, endothelium and soluble factors (Fig. 4). Increas- ventions to decrease early necrosis and prevent un-
ing evidence has linked T cells with vasoactive sub- wanted T cell activation may be useful to prevent CAN.
stances, including angiotensin II [96], and thus the T cell Native kidney progressive renal disease, be it from diabe-
could have an effect on renal hemodynamics. tes, hypertension, chronic glomerulonephritis or polycys-
The T cell lifespan is characterized by circulation tic kidney disease, is characterized by an interstitial
through blood and lymphoid tissue. Though it would be mononuclear cell infiltrate that correlates highly with
conceptually simpler if the T cell had a direct effect rapid progression. Neither the factors that lead to this
in IRI that required adhesion with the cells that were lymphocyte infiltration into the interstitium, nor the ef-
dysfunctional, an indirect and/or distant effect may well fects of this smoldering lymphocyte activity are known.
be occurring. T cells lodged in spleen, local lymph nodes In addition, important cytokines implicated in the patho-
or bone marrow could well have a role. However, we genesis of progressive renal failure, such as transforming
did not find a protection from renal IRI in the splenecto- growth factor- (TGF-), have a crucial role in T cell
mized aly/aly mouse [97], which lacked spleen and lymph functions and may well interplay. Recently, mycopheno-
nodes. Therefore, absence of these lymph organs was late, an immunosuppressive compound widely used in
insufficient to alter the course of IRI (Yokota and Rabb, organ transplantation, has been shown to decrease pro-
unpublished data). If T cells did work from a distance, or teinuria and renal injury in chronic progressive renal
mediated IRI via the production of cytokines, an obvious failure models, suggesting a potential role for T cells
question is whether this occurs via the classic T cell TH1 in this alloantigen independent process [101–103]. The
(IL-2, IFG) or TH2 (IL-4) pathway. T cell polarization recognition of an important role for T cells in the early
into one of these pathways underlies the pathogenesis injury response to ischemia also should stimulate new
of a number of diseases from leprosy to schistosomiasis. basic research into T cell biology to explain how the
Asthma is characterized by a deleterious TH2 response, T cell is participating in the innate immune response.
while acute transplant rejection is mainly a TH1 response
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